TABLE 01. COMPLETED CLINICAL TRIALS IN ORAL PROTEIN AND PEPTIDES MARKET
TABLE 02. GLOBAL ORAL PROTEINS AND PEPTIDES MARKET, BY DRUG TYPE, 2016-2023 ($MILLION)
TABLE 03. GLOBAL ORAL PROTEINS AND PEPTIDES MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 04. ORAL PROTEINS AND PEPTIDES MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 05. ALLERGAN: COMPANY SNAPSHOT
TABLE 06. ALLERGAN: OPERATING SEGMENTS
TABLE 07. ALLERGAN: PRODUCT PORTFOLIO
TABLE 08. ASTRAZENECA: COMPANY SNAPSHOT
TABLE 09. ASTRAZENECA: PRODUCT PORTFOLIO
TABLE 10. BIOCON: COMPANY SNAPSHOT
TABLE 11. BIOCON: OPERATING SEGMENTS
TABLE 12. BIOCON: PRODUCT PORTFOLIO
TABLE 13. CHIASMA: COMPANY SNAPSHOT
TABLE 14. CHIASMA: PRODUCT PORTFOLIO
TABLE 15. GENEREX: COMPANY SNAPSHOT
TABLE 16. GENEREX: OPERATING SEGMENTS
TABLE 17. GENEREX: PRODUCT PORTFOLIO
TABLE 18. NOVO NORDISK: COMPANY SNAPSHOT
TABLE 19. NOVO NORDISK: OPERATING SEGMENTS
TABLE 20. NOVO NORDISK: PRODUCT PORTFOLIO
TABLE 21. ORAMED: COMPANY SNAPSHOT
TABLE 22. ORAMED: PRODUCT PORTFOLIO
TABLE 23. PROXIMA CONCEPTS: COMPANY SNAPSHOT
TABLE 24. PROXIMA CONCEPTS: OPERATING SEGMENTS
TABLE 25. PROXIMA CONCEPTS: PRODUCT PORTFOLIO
TABLE 26. SYNERGY: COMPANY SNAPSHOT
TABLE 27. SYNERGY: PRODUCT PORTFOLIO
TABLE 28. TARSA: COMPANY SNAPSHOT
TABLE 29. TARSA: PRODUCT PORTFOLIO

LIST OF FIGURE

FIGURE 01. ORAL PROTEINS AND PEPTIDES MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS, 2028
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2015-2018*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2018* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2015-2018*
FIGURE 06. TOP PLAYER POSITIONING, 2018
FIGURE 07. PATENT REGISTERED/APPROVED, BY YEAR
FIGURE 08. PATENT REGISTERED, BY COUNTRY
FIGURE 09. ORAL PROTEINS AND PEPTIDES MARKET: IMPACT ANALYSES
FIGURE 10. DIABETES BURDEN: KEY TAKEAWAYS, 2014
FIGURE 11. GLOBAL ELDERLY POPULATION (AGED 65 AND ABOVE), BY REGION (2015, 2030, AND 2050)
FIGURE 12. ORAL PROTEINS AND PEPTIDES MARKET SEGMENTATION, BY DRUG TYPE
FIGURE 13. ORAL PROTEINS AND PEPTIDES MARKET FOR LINACLOTIDE, 2016-2028 ($MILLION)
FIGURE 14. ORAL PROTEINS AND PEPTIDES MARKET FOR PLECANATIDE, 2017-2028 ($MILLION)
FIGURE 15. ORAL PROTEINS AND PEPTIDES MARKET FOR CALCITONIN, 2020-2028 ($MILLION)
FIGURE 16. ORAL PROTEINS AND PEPTIDES MARKET FOR INSULIN, 2020-2028 ($MILLION)
FIGURE 17. ORAL PROTEINS AND PEPTIDES MARKET FOR OCTREOTIDE, 2022-2028 ($MILLION)
FIGURE 18. ORAL PROTEINS AND PEPTIDES MARKET SEGMENTATION, BY APPLICATION
FIGURE 19. ORAL PROTEINS AND PEPTIDES MARKET FOR GASTRIC & DIGESTIVE DISORDERS, 2016-2028 ($MILLION)
FIGURE 20. ORAL PROTEINS AND PEPTIDES MARKET FOR BONE DISEASES, 2017-2028 ($MILLION)
FIGURE 21. ORAL PROTEINS AND PEPTIDES MARKET FOR DIABETES, 2020-2028 ($MILLION)
FIGURE 22. ORAL PROTEINS AND PEPTIDES MARKET FOR HORMONAL DISORDERS, 2022-2028 ($MILLION)
FIGURE 23. ORAL PROTEINS AND PEPTIDES MARKET SEGMENTATION, BY REGION
FIGURE 24. U.S. ORAL PROTEINS AND PEPTIDES MARKET, 2016-2028 ($MILLION)
FIGURE 25. REST OF THE WORLD ORAL PROTEINS AND PEPTIDES MARKET, 2017-2028 ($MILLION)
FIGURE 26. ALLERGAN: NET SALES, 2015-2017 ($MILLION)
FIGURE 27. ALLERGAN: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 28. ASTRAZENECA: NET SALES, 2015-2017 ($MILLION)
FIGURE 29. ASTRAZENECA: REVENUE SHARE BY PRODUCT, 2017 (%)
FIGURE 30. ASTRAZENECA: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 31. BIOCON: NET SALES, 2015-2017 ($MILLION)
FIGURE 32. BIOCON: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 33. BIOCON: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 34. NOVO NORDISK: NET SALES, 2015-2017 ($MILLION)
FIGURE 35. NOVO NORDISK: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 36. NOVO NORDISK: REVENUE SHARE BY GEOGRAPHY, 2017 (%)